A15.6 Tuberculous pleurisy

Name of the Condition

• Tuberculous pleurisy (ICD-10-CM: A15.6)

Summary

Tuberculous pleurisy is a form of tuberculosis (TB) that involves inflammation of the pleura, the membrane surrounding the lungs. It is caused by Mycobacterium tuberculosis and typically results from the spread of TB infection to the pleural space. This condition may occur as a complication of primary or reactivated pulmonary TB and is characterized by fluid accumulation in the pleural cavity.

Causes

Tuberculous pleurisy is caused by the bacterium Mycobacterium tuberculosis. Infection occurs when a person inhales respiratory droplets containing the bacteria, typically from an individual with active TB. The bacteria can spread from the lungs to the pleural space, leading to inflammation and fluid buildup. This may happen during primary infection or as a result of reactivation of latent TB.

Risk Factors

• Prolonged exposure to someone with active TB.
• Living in or traveling to areas with high TB prevalence.
• Compromised immune system (e.g., HIV/AIDS, diabetes).
• Substance abuse, including alcohol and tobacco.
• Malnutrition or poor living conditions.
• History of prior TB infection.

Symptoms

• Chest pain, often sharp and worsened by breathing or coughing.
• Shortness of breath (dyspnea).
• Persistent cough.
• Fever, chills, and night sweats.
• Unintended weight loss.
• Fatigue and weakness.

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging, and laboratory tests. A chest X-ray or CT scan may reveal pleural effusion or other abnormalities. Thoracentesis (fluid removal) is performed to analyze pleural fluid for TB bacteria, often using microscopy, culture, or molecular testing. Additional tests may include sputum analysis or biopsy of pleural tissue to confirm the diagnosis.

Treatment Options

Treatment typically involves a standard course of anti-TB medications, such as isoniazid, rifampin, pyrazinamide, and ethambutol, administered for several months. Drainage of pleural fluid may be necessary to relieve symptoms and improve lung function. In some cases, corticosteroids may be used to reduce inflammation, though their use is carefully considered based on individual patient factors.

Prognosis and Follow-Up

With appropriate treatment, most patients recover fully, though recovery may take several months. Follow-up care includes monitoring for treatment response, potential side effects of medications, and signs of recurrence. Regular imaging or fluid analysis may be performed to ensure resolution of the pleural effusion and absence of residual infection.

Complications

• Persistent pleural effusion or fibrosis.
• Spread of infection to other parts of the body.
• Respiratory distress due to large fluid collections.
• Drug-resistant TB, if treatment is incomplete or ineffective.

Lifestyle & Prevention

• Avoid close contact with individuals known to have active TB.
• Ensure proper ventilation in living or work environments.
• Maintain a healthy immune system through balanced nutrition and regular exercise.
• Complete prescribed TB treatment to prevent recurrence or drug resistance.
• Seek medical evaluation if exposed to TB or experiencing symptoms.

When to Seek Professional Help

Seek immediate medical attention if you experience severe chest pain, difficulty breathing, or unexplained weight loss. Prompt evaluation is important if you have a persistent cough, fever, or other symptoms of TB, especially if you have risk factors for the disease.

Tips for Medical Coders

When coding for tuberculous pleurisy (A15.6), ensure documentation supports the diagnosis, including clinical findings, imaging results, and laboratory confirmation of TB infection. Note the presence of pleural effusion or other pleural involvement, as this distinguishes it from other TB manifestations. Verify that the code aligns with the specific anatomical site and type of TB documented in the medical record.